Deciphera Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/15/2024

Shares

398,540

Value ($000)

6,269

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/15/2024	6,269	0.0%	398,540	3/31/2024
2023 Q4	2/14/2024	6,453	0.0%	400,044	12/31/2023
2023 Q3	11/13/2023	5,125	0.0%	402,898	9/30/2023
2023 Q2	8/11/2023	6,432	0.0%	416,306	6/30/2023
2023 Q1	5/15/2023	6,432	0.0%	416,306	3/31/2023
2022 Q4	2/14/2023	589	0.0%	35,951	12/31/2022
2022 Q3	11/14/2022	974	0.0%	52,637	9/30/2022
2022 Q2	8/12/2022	664	0.0%	50,511	6/30/2022
2022 Q1	5/16/2022	414	0.0%	44,674	3/31/2022
2021 Q4	2/14/2022	436	0.0%	44,674	12/31/2021
2021 Q3	11/15/2021	12,152	0.0%	357,623	9/30/2021
2021 Q2	8/16/2021	14,387	0.0%	392,978	6/30/2021
2021 Q1	5/14/2021	12,815	0.0%	285,801	3/31/2021
2020 Q4	3/1/2021	22,155	0.0%	388,211	12/31/2020
2020 Q3	11/13/2020	14,538	0.0%	283,389	9/30/2020
2020 Q2	8/14/2020	16,167	0.0%	270,713	6/30/2020
2020 Q1	5/15/2020	11,668	0.0%	283,402	3/31/2020
2019 Q4	2/14/2020	19,403	0.0%	311,744	12/31/2019